Medical weight loss uses medications, clinical monitoring, and personalized support to address the biological factors that make weight loss challenging. These medications help regulate appetite, improve insulin sensitivity, reduce cravings, and support healthier metabolic function—making it easier to achieve and maintain weight loss.

Physicians evaluate your BMI, overall health, and conditions such as insulin resistance or high blood pressure to determine whether you are eligible for medication.

Semaglutide is a GLP-1 medication that helps control hunger and stabilize blood sugar. Tirzepatide acts on both the GLP-1 and GIP pathways, providing stronger appetite control and often more rapid or greater weight loss. Both are effective; the best option depends on your goals, medical history, and your body's response.

Yes—when prescribed by trained physicians and used as directed. Semaglutide and tirzepatide are prescription medications that have undergone extensive clinical trials showing strong safety profiles. Your provider monitors your dosing, progress, and any side effects to ensure treatment remains safe and effective for your individual health needs.

Many patients notice reduced hunger and cravings within 1–3 weeks. Visible weight loss typically begins within 3–8 weeks as your metabolism adjusts, with continued improvement when combined with healthy habits and support.

Strict dieting isn't required, but eating balanced meals, prioritizing protein, and staying hydrated can help you feel your best and optimize results. These medications naturally reduce appetite, making it easier to make healthier choices without feeling deprived or restricted.

Weight regain varies from person to person. Because these medications treat underlying metabolic issues, some people maintain their progress after stopping. However, lifestyle habits and continued support play a significant role. Your physician can help you transition off medication gradually and maintain your results long-term.

Common side effects, such as mild nausea or digestive changes, typically occur during dose escalation and often improve over time. These are monitored closely, and your physician will adjust your plan to minimize discomfort and ensure safety.

Treatment duration varies based on your goals and clinical needs. Many patients remain on medication until they reach a healthy, stable weight and feel confident maintaining it. Some continue treatment longer to support metabolic health or prevent regain. Your physician will guide you through each phase.

In many cases, yes. People with insulin resistance, prediabetes, PCOS, or elevated blood sugar often benefit significantly from GLP-1 or GIP/GLP-1 therapies. Your physician will review your medical history, current medications, and lab work to ensure treatment is safe and appropriate for your situation.